Virtual Reality Exposure Therapy for Reducing School Anxiety in Adolescents: Pilot Study
- PMID: 39499549
- PMCID: PMC11576610
- DOI: 10.2196/56235
Virtual Reality Exposure Therapy for Reducing School Anxiety in Adolescents: Pilot Study
Abstract
Background: Virtual reality exposure therapy (VRET) is a promising treatment approach for anxiety disorders. However, while its efficacy has been demonstrated in adults, research on the efficacy of VRET in the treatment of adolescents with anxiety disorders is largely lacking.
Objective: A pilot study was carried out to test whether exposure to a virtual reality (VR) school environment elicits state anxiety and autonomic arousal in adolescents with school anxiety (diagnoses covering social anxiety disorder or specific phobia involving school contexts). In addition, we examined whether repeated VR exposure led to a reduction in this fear response, trait school anxiety, and social anxiety symptoms. Moreover, the relationship of presence, the subjective sense of "being there," during VR exposure with anxiety measures and treatment response was examined.
Methods: In a pilot study, 10 adolescents with school anxiety (age range 14 to 17 years) participated in five VRET sessions. Self-reported state anxiety, heart rate, and presence during exposure, as well as trait school anxiety and social anxiety before and after treatment, were measured.
Results: The VR scenario induced state anxiety and autonomic arousal. After VRET, a significant reduction in state anxiety (η2=0.74) and social anxiety symptoms (d=0.82) as well as a trend toward a decrease in trait school anxiety were observed, while autonomic arousal did not change. In addition, presence during VR exposure was associated with state anxiety and treatment response.
Conclusions: Our findings indicate the feasibility and potential effectiveness of VRET as a treatment method for symptoms of school and social anxiety in adolescents.
Keywords: VR; VRET; adolescents; autonomic arousal; digital health; exposure therapy; posttreatment; school anxiety; simulation; social anxiety; virtual reality; virtual reality exposure therapy.
©Gesa Beele, Paula Liesong, Sabine Bojanowski, Kristian Hildebrand, Malte Weingart, Julia Asbrand, Christoph U Correll, Nexhmedin Morina, Peter J Uhlhaas. Originally published in JMIR Mental Health (https://mental.jmir.org), 05.11.2024.
Conflict of interest statement
Conflicts of Interest: CU Correll has been a consultant and/or advisor to or has received honoraria from: AbbVie, Acadia, Adock Ingram, Alkermes, Allergan, Angelini, Aristo, Biogen, Boehringer-Ingelheim, Bristol-Meyers Squibb, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Delpor, Denovo, Eli Lilly, Gedeon Richter, Hikma, Holmusk, IntraCellular Therapies, Jamjoom Pharma, Janssen/J&J, Karuna, LB Pharma, Lundbeck, MedInCell, MedLink, Merck, Mindpax, Mitsubishi Tanabe Pharma, Maplight, Mylan, Neumora Therapeutics, Neurocrine, Neurelis, Newron, Noven, Novo Nordisk, Otsuka, PPD Biotech, Recordati, Relmada, Reviva, Rovi, Sage, Saladax, Sanofi, Seqirus, SK Life Science, Sumitomo Pharma America, Sunovion, Sun Pharma, Supernus, Tabuk, Takeda, Teva, Terran, Tolmar, Vertex, Viatris and Xenon Pharmaceuticals. He provided expert testimony for Janssen, Lundbeck and Otsuka. He served on a Data Safety Monitoring Board for Compass Pathways, Denovo, IntraCellular Therapies, Lundbeck, Relmada, Reviva, Rovi, Supernus, and Teva. He has received grant support from Boehringer-Ingelheim, Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics, Kuleon Biosciences, LB Pharma, Medlink, Mindpax, Quantic, Terran.
Figures



Similar articles
-
Exposure to virtual social interactions in the treatment of social anxiety disorder: A randomized controlled trial.Behav Res Ther. 2016 Feb;77:147-56. doi: 10.1016/j.brat.2015.12.016. Epub 2015 Dec 29. Behav Res Ther. 2016. PMID: 26752328 Clinical Trial.
-
Virtual reality exposure therapy for anxiety and related disorders: A meta-analysis of randomized controlled trials.J Anxiety Disord. 2019 Jan;61:27-36. doi: 10.1016/j.janxdis.2018.08.003. Epub 2018 Aug 10. J Anxiety Disord. 2019. PMID: 30287083
-
Efficacy of virtual reality exposure therapy for treatment of dental phobia: a randomized control trial.BMC Oral Health. 2016 Feb 27;16:25. doi: 10.1186/s12903-016-0186-z. BMC Oral Health. 2016. PMID: 26920573 Free PMC article. Clinical Trial.
-
[The application of virtual reality in the treatment of mental disorders].Nervenarzt. 2023 Jan;94(1):27-33. doi: 10.1007/s00115-022-01378-z. Epub 2022 Sep 2. Nervenarzt. 2023. PMID: 36053303 Free PMC article. Review. German.
-
Lack of research on efficacy of virtual reality exposure therapy (VRET) for anxiety disorders in children and adolescents : A systematic review.Neuropsychiatr. 2021 Jun;35(2):68-75. doi: 10.1007/s40211-020-00349-7. Epub 2020 May 5. Neuropsychiatr. 2021. PMID: 32372291 Free PMC article.
Cited by
-
VIRTUS: virtual reality exposure training for adolescents with social anxiety - a randomized controlled trial.BMC Psychiatry. 2025 Apr 18;25(1):401. doi: 10.1186/s12888-025-06756-w. BMC Psychiatry. 2025. PMID: 40251576 Free PMC article. Clinical Trial.
References
-
- Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Green JG, Gruber MJ, He JP, Koretz D, McLaughlin KA, Petukhova M, Sampson NA, Zaslavsky AM, Merikangas KR. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry. 2012;69(4):372–380. doi: 10.1001/archgenpsychiatry.2011.160. https://europepmc.org/abstract/MED/22147808 archgenpsychiatry.2011.160 - DOI - PMC - PubMed
-
- Richards HJ, Hadwin JA. An exploration of the relationship between trait anxiety and school attendance in young people. School Mental Health. 2011;3(4):236–244. doi: 10.1007/s12310-011-9054-9. - DOI
-
- Melfsen S, Walitza S. Soziale Ängste und Schulangst: Entwicklungsrisiken Erkennen und Behandeln. Geneva: Beltz Verlag; 2013.
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical